Assessment of Physicochemical Properties of Rituximab Related to Its Immunomodulatory Activity

Rituximab is a chimeric monoclonal antibody employed for the treatment of CD20-positive B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis. It binds specifically to the CD20 antigen expressed on pre-B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunol Res
Autors principals: Miranda-Hernández, Mariana P., López-Morales, Carlos A., Ramírez-Ibáñez, Nancy D., Piña-Lara, Nelly, Pérez, Nestor O., Molina-Pérez, Aarón, Revilla-Beltri, Jorge, Flores-Ortiz, Luis F., Medina-Rivero, Emilio
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418000/
https://ncbi.nlm.nih.gov/pubmed/25973441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/910763
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars